Antitumor effects of vitamin B12 <i>in vitro</i>, <i>in vivo</i>, <i>in silico</i>
Objective: to investigate the antitumor effects of various forms of vitamin B12 in combination with various synergistic vitamins and evaluate the prospects for clinical applications.Material and methods. Cell lines BT-474 (breast ductal carcinoma) and A549 (lung carcinoma) were used as an in vitro c...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IRBIS LLC
2023-09-01
|
| Series: | Фармакоэкономика |
| Subjects: | |
| Online Access: | https://www.pharmacoeconomics.ru/jour/article/view/989 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850031649149943808 |
|---|---|
| author | O. A. Gromova D. E. Frolova I. Yu. Torshin M. V. Filimonova M. A. Sorokina I. A. Reyer O. A. Limanova L. E. Fedotova L. A. Maiorova |
| author_facet | O. A. Gromova D. E. Frolova I. Yu. Torshin M. V. Filimonova M. A. Sorokina I. A. Reyer O. A. Limanova L. E. Fedotova L. A. Maiorova |
| author_sort | O. A. Gromova |
| collection | DOAJ |
| description | Objective: to investigate the antitumor effects of various forms of vitamin B12 in combination with various synergistic vitamins and evaluate the prospects for clinical applications.Material and methods. Cell lines BT-474 (breast ductal carcinoma) and A549 (lung carcinoma) were used as an in vitro cell model, and transplantable epidermoid Lewis lung carcinoma (LLC) was used as an in vivo animal tumor model. Animal studies of LLC were carried out on 25 male F1 hybrid mice (age 2.5–3 months, body weight 23–26 g). In silico research was conducted as a systematic computer analysis of 9,326 scientific sources.Results. In vitro studies on cultures of two human tumor cell lines (BT-474 and A549) confirmed the cytotoxic effect of vitamin B12 (aquacobalamin). It has been shown that vitamin B12 has weak cytotoxic properties in the concentration range of 3.125–200 μg/L (IC50>200 nM), and its hydrophobic derivative (heptamethyl cyanoquacobyric acid ester) significantly reduces the survival of tumor lines. BT-474 and A549 cells at high concentrations (100–200 µg/l, IC50~100 nM). Experimental animals with an in vivo LLС model easily tolerated a drug based on vitamin B12. Exposure to the drug up to the 21st day of LLС development was accompanied by an increasing tendency to inhibit tumor growth by 10–20% (р=0.059). The results of a systematic in silico review of the literature show that clinical data confirmed the significant antitumor effect of vitamin B12.Conclusion. The cellular model indicated the antitumor properties of vitamin B12 and its hydrophobic derivative. With subchronic intragastric administration of B12 to tumor-bearing animals, a steady tendency to inhibit the LLС growth was observed. Analysis of clinical data confirmed the feasibility of the antitumor use of vitamin B12 individually and in combination with synergistic vitamins. |
| format | Article |
| id | doaj-art-e1bfa89d3ac6421c919b021fa281e6b4 |
| institution | DOAJ |
| issn | 2070-4909 2070-4933 |
| language | Russian |
| publishDate | 2023-09-01 |
| publisher | IRBIS LLC |
| record_format | Article |
| series | Фармакоэкономика |
| spelling | doaj-art-e1bfa89d3ac6421c919b021fa281e6b42025-08-20T02:58:54ZrusIRBIS LLCФармакоэкономика2070-49092070-49332023-09-010010.17749/2070-4909/farmakoekonomika.2024.231479Antitumor effects of vitamin B12 <i>in vitro</i>, <i>in vivo</i>, <i>in silico</i>O. A. Gromova0D. E. Frolova1I. Yu. Torshin2M. V. Filimonova3M. A. Sorokina4I. A. Reyer5O. A. Limanova6L. E. Fedotova7L. A. Maiorova8Federal Research Center “Computer Science and Control”, Russian Academy of SciencesIvanovo State Medical AcademyFederal Research Center “Computer Science and Control”, Russian Academy of SciencesTsyba Medical Radiological Research Center – branch of Scientific Medical Research Center of RadiologyPirogov Russian National Research Medical UniversityFederal Research Center “Computer Science and Control”, Russian Academy of SciencesIvanovo State Medical AcademyIvanovo State Medical AcademyFederal Research Center “Computer Science and Control”, Russian Academy of Sciences; Ivanovo State University of Chemistry and TechnologyObjective: to investigate the antitumor effects of various forms of vitamin B12 in combination with various synergistic vitamins and evaluate the prospects for clinical applications.Material and methods. Cell lines BT-474 (breast ductal carcinoma) and A549 (lung carcinoma) were used as an in vitro cell model, and transplantable epidermoid Lewis lung carcinoma (LLC) was used as an in vivo animal tumor model. Animal studies of LLC were carried out on 25 male F1 hybrid mice (age 2.5–3 months, body weight 23–26 g). In silico research was conducted as a systematic computer analysis of 9,326 scientific sources.Results. In vitro studies on cultures of two human tumor cell lines (BT-474 and A549) confirmed the cytotoxic effect of vitamin B12 (aquacobalamin). It has been shown that vitamin B12 has weak cytotoxic properties in the concentration range of 3.125–200 μg/L (IC50>200 nM), and its hydrophobic derivative (heptamethyl cyanoquacobyric acid ester) significantly reduces the survival of tumor lines. BT-474 and A549 cells at high concentrations (100–200 µg/l, IC50~100 nM). Experimental animals with an in vivo LLС model easily tolerated a drug based on vitamin B12. Exposure to the drug up to the 21st day of LLС development was accompanied by an increasing tendency to inhibit tumor growth by 10–20% (р=0.059). The results of a systematic in silico review of the literature show that clinical data confirmed the significant antitumor effect of vitamin B12.Conclusion. The cellular model indicated the antitumor properties of vitamin B12 and its hydrophobic derivative. With subchronic intragastric administration of B12 to tumor-bearing animals, a steady tendency to inhibit the LLС growth was observed. Analysis of clinical data confirmed the feasibility of the antitumor use of vitamin B12 individually and in combination with synergistic vitamins.https://www.pharmacoeconomics.ru/jour/article/view/989lung carcinomacell modelsvitamin b12systems biologybioinformaticsexperimental pharmacology |
| spellingShingle | O. A. Gromova D. E. Frolova I. Yu. Torshin M. V. Filimonova M. A. Sorokina I. A. Reyer O. A. Limanova L. E. Fedotova L. A. Maiorova Antitumor effects of vitamin B12 <i>in vitro</i>, <i>in vivo</i>, <i>in silico</i> Фармакоэкономика lung carcinoma cell models vitamin b12 systems biology bioinformatics experimental pharmacology |
| title | Antitumor effects of vitamin B12 <i>in vitro</i>, <i>in vivo</i>, <i>in silico</i> |
| title_full | Antitumor effects of vitamin B12 <i>in vitro</i>, <i>in vivo</i>, <i>in silico</i> |
| title_fullStr | Antitumor effects of vitamin B12 <i>in vitro</i>, <i>in vivo</i>, <i>in silico</i> |
| title_full_unstemmed | Antitumor effects of vitamin B12 <i>in vitro</i>, <i>in vivo</i>, <i>in silico</i> |
| title_short | Antitumor effects of vitamin B12 <i>in vitro</i>, <i>in vivo</i>, <i>in silico</i> |
| title_sort | antitumor effects of vitamin b12 i in vitro i i in vivo i i in silico i |
| topic | lung carcinoma cell models vitamin b12 systems biology bioinformatics experimental pharmacology |
| url | https://www.pharmacoeconomics.ru/jour/article/view/989 |
| work_keys_str_mv | AT oagromova antitumoreffectsofvitaminb12iinvitroiiinvivoiiinsilicoi AT defrolova antitumoreffectsofvitaminb12iinvitroiiinvivoiiinsilicoi AT iyutorshin antitumoreffectsofvitaminb12iinvitroiiinvivoiiinsilicoi AT mvfilimonova antitumoreffectsofvitaminb12iinvitroiiinvivoiiinsilicoi AT masorokina antitumoreffectsofvitaminb12iinvitroiiinvivoiiinsilicoi AT iareyer antitumoreffectsofvitaminb12iinvitroiiinvivoiiinsilicoi AT oalimanova antitumoreffectsofvitaminb12iinvitroiiinvivoiiinsilicoi AT lefedotova antitumoreffectsofvitaminb12iinvitroiiinvivoiiinsilicoi AT lamaiorova antitumoreffectsofvitaminb12iinvitroiiinvivoiiinsilicoi |